Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host dis (Q45009148)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host dis |
scientific article |
Statements
1 reference
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host dis (English)
1 reference
Joseph H Antin
1 reference
Jerome Ritz
1 reference
Stephanie Lee
1 reference
Daniel J DeAngelo
1 reference
Ephraim P Hochberg
1 reference
Edwin P Alyea
1 reference
Janina Longtine
1 reference
Ilene Galinsky
1 reference
Ben Parekkedon
1 reference
Richard M Stone
1 reference
Robert J Soiffer
1 reference
1 August 2004
1 reference
1 reference
Identifiers
1 reference